Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, September 13, 2023.
Procept BioRobotics this week won an FDA investigational device exemption (IDE) for its Aquablation prostate cancer therapy. Fast Five hosts Danielle Kirsh and Sean Whooley explain what the therapy is and what the company’s plans are for the IDE. Read more here>>
The FDA has approved LimFlow’s chronic limb-threatening ischemia (CLTI) treatment device. The approval enables the treatment to help those with CLTI with no other suitable endovascular or surgical treatment options available. Whooley dives into the device design in this episode. Read more here>>
Shockwave Medical is appointing a former Abbott Vascular executive as its chief medical officer. Find out who’s taking on this role and what their career history is. Read more here>>
Bausch+Lomb launched a sizeable offering of senior secured notes worth $1.4 billion. Whooley explains the purpose behind the offering and provides more details into the company’s latest acquisition. Read more here>>
Orthofix this week fired its CEO and two other executives with cause. After the announcement, analysts downgraded the company. The Fast Five hosts talk about the terminations, why the board made this decision and what analysts were thinking. Read more here>>
Subscribe to the Fast Five daily news podcast on your preferred listening platform. If you’re on a desktop computer, scan the QR code below with your smartphone to easily access the podcast on your mobile device.
Listen to previous episodes here.